These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
185 related articles for article (PubMed ID: 23639512)
1. P53 codon 72 polymorphism in Taiwanese breast cancer patients. Chen FM; Ou-Yang F; Yang SF; Tsai EM; Hou MF Kaohsiung J Med Sci; 2013 May; 29(5):259-64. PubMed ID: 23639512 [TBL] [Abstract][Full Text] [Related]
2. p53 Codon 72 polymorphism predicts the pathologic response to neoadjuvant chemotherapy in patients with breast cancer. Xu Y; Yao L; Ouyang T; Li J; Wang T; Fan Z; Lin B; Lu Y; Xie Y Clin Cancer Res; 2005 Oct; 11(20):7328-33. PubMed ID: 16243804 [TBL] [Abstract][Full Text] [Related]
3. P27 V109G Polymorphism is associated with lymph node metastases but not with increased risk of breast cancer. Naidu R; Har YC; Taib NA J Exp Clin Cancer Res; 2007 Mar; 26(1):133-40. PubMed ID: 17550142 [TBL] [Abstract][Full Text] [Related]
4. p53 codon 72 polymorphism as a risk factor in the development of breast cancer. Papadakis EN; Dokianakis DN; Spandidos DA Mol Cell Biol Res Commun; 2000 Jun; 3(6):389-92. PubMed ID: 11032762 [TBL] [Abstract][Full Text] [Related]
5. P53 codon 72 polymorphism in breast cancer. Buyru N; Tigli H; Dalay N Oncol Rep; 2003; 10(3):711-4. PubMed ID: 12684648 [TBL] [Abstract][Full Text] [Related]
6. P53 codon 72 and HER2 codon 655 polymorphisms in Turkish breast cancer patients. Kara N; Karakus N; Ulusoy AN; Ozaslan C; Gungor B; Bagci H DNA Cell Biol; 2010 Jul; 29(7):387-92. PubMed ID: 20380571 [TBL] [Abstract][Full Text] [Related]
7. p53 gene mutations and codon 72 polymorphism in ovarian carcinoma patients from Serbia. Malisic E; Jankovic R; Slavkovic D; Milovic-Kovacevic M; Radulovic S J BUON; 2010; 15(1):101-6. PubMed ID: 20414935 [TBL] [Abstract][Full Text] [Related]
8. p53 codon 72 polymorphism was associated with vulnerability, progression, but not prognosis of bladder cancer in a Taiwanese population: an implication of structural equation modeling to manage the risks of bladder cancer. Lin HY; Huang CH; Yu TJ; Wu WJ; Yang MC; Lung FW Urol Int; 2011; 86(3):355-60. PubMed ID: 21346315 [TBL] [Abstract][Full Text] [Related]
9. P53 codon 72 (Arg72Pro) polymorphism and prostate cancer risk: association between disease onset and proline genotype. Rogler A; Rogenhofer M; Borchardt A; Lunz JC; Knoell A; Hofstaedter F; Tannapfel A; Wieland W; Hartmann A; Stoehr R Pathobiology; 2011; 78(4):193-200. PubMed ID: 21778786 [TBL] [Abstract][Full Text] [Related]
10. Lack of evidence that proline homozygosity at codon 72 of p53 and rare arginine allele at codon 31 of p21, jointly mediate cervical cancer susceptibility among Indian women. Bhattacharya P; Sengupta S Gynecol Oncol; 2005 Oct; 99(1):176-82. PubMed ID: 16054204 [TBL] [Abstract][Full Text] [Related]
11. Polymorphism of TP53 codon 72 showed no association with breast cancer in Iranian women. Khadang B; Fattahi MJ; Talei A; Dehaghani AS; Ghaderi A Cancer Genet Cytogenet; 2007 Feb; 173(1):38-42. PubMed ID: 17284368 [TBL] [Abstract][Full Text] [Related]
12. p53 codon 72 polymorphism in Taiwanese lung cancer patients: association with lung cancer susceptibility and prognosis. Wang YC; Chen CY; Chen SK; Chang YY; Lin P Clin Cancer Res; 1999 Jan; 5(1):129-34. PubMed ID: 9918210 [TBL] [Abstract][Full Text] [Related]
13. Association of p53 genetic polymorphism (Arg72Pro) with estrogen receptor positive breast cancer risk in Japanese women. Noma C; Miyoshi Y; Taguchi T; Tamaki Y; Noguchi S Cancer Lett; 2004 Jul; 210(2):197-203. PubMed ID: 15183535 [TBL] [Abstract][Full Text] [Related]
14. Evidence for an association of TP53 codon 72 polymorphism with breast cancer risk. Damin AP; Frazzon AP; Damin DC; Roehe A; Hermes V; Zettler C; Alexandre CO Cancer Detect Prev; 2006; 30(6):523-9. PubMed ID: 17113725 [TBL] [Abstract][Full Text] [Related]
15. Association between polymorphisms of the BRCA2 gene and clinical parameters in breast cancer. Krupa R; Sliwinski T; Morawiec Z; Pawlowska E; Zadrozny M; Blasiak J Exp Oncol; 2009 Dec; 31(4):250-1. PubMed ID: 20010525 [TBL] [Abstract][Full Text] [Related]
16. Association of functional -509C>T polymorphism in the TGF-β1 gene with infiltrating ductal breast carcinoma risk in a Russian Western Siberian population. Babyshkina N; Malinovskaya E; Stakheyeva M; Volkomorov V; Slonimskaya E; Maximov V; Cherdyntseva N Cancer Epidemiol; 2011 Dec; 35(6):560-3. PubMed ID: 21470928 [TBL] [Abstract][Full Text] [Related]
17. P53 codon 72 polymorphism contributes to breast cancer risk: a meta-analysis based on 39 case-control studies. Zhang Z; Wang M; Wu D; Wang M; Tong N; Tian Y; Zhang Z Breast Cancer Res Treat; 2010 Apr; 120(2):509-17. PubMed ID: 19629678 [TBL] [Abstract][Full Text] [Related]
18. Evaluation of breast cancer susceptibility loci on 2q35, 3p24, 17q23 and FGFR2 genes in Taiwanese women with breast cancer. Lin CY; Ho CM; Bau DT; Yang SF; Liu SH; Lin PH; Lin TH; Tien N; Shih MC; Lu JJ Anticancer Res; 2012 Feb; 32(2):475-82. PubMed ID: 22287734 [TBL] [Abstract][Full Text] [Related]
19. Dynamic role of the codon 72 p53 single-nucleotide polymorphism in mammary tumorigenesis in a humanized mouse model. Gunaratna RT; Santos A; Luo L; Nagi C; Lambertz I; Spier M; Conti CJ; Fuchs-Young RS Oncogene; 2019 May; 38(18):3535-3550. PubMed ID: 30651598 [TBL] [Abstract][Full Text] [Related]
20. Role of p53 Codon72 SNP in breast cancer risk and anthracycline resistance. Arfaoui A; Douik H; Kablouti G; Chaaben AB; Handiri N; Zid Z; Ouni N; Zouiouch F; Ayari F; Mamoughli T; Bouassida J; Abazza H; Harzallaha L; Guemira F Anticancer Res; 2015 Mar; 35(3):1763-9. PubMed ID: 25750340 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]